Standout Papers

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects 2022 2026 2023 2024114
  1. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects (2022)
    Shengjie Tang, Chao Qin et al. Cells

Citation Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Advances in chitosan-based drug delivery systems: A comprehensive review for therapeutic applications
2024 Standout
Macrophage polarization: an important role in inflammatory diseases
2024 Standout
2 intermediate papers

Works of Hang Yan being referenced

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
2022
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals
2020

Author Peers

Author Molecular Biology PRM Oncology Last Decade Papers Cites
Hang Yan 361 108 145 27 620
M. Meurant 119 1 18 341
Sven K.‐H. Thiele 9 14 15 639
Rudolf Bayer 24 2 18 460
Xiaofan Su 99 69 28 15 240
Mustafa Grit 469 57 37 9 770

All Works

Loading papers...

Rankless by CCL
2026